Executive Director and Head of DMPK @ (September 2020 - May 2023)
Director of Drug Metabolism and Pharmacokinetics @ (November 2014 - September 2020)
Scientific Director @ (January 2004 - October 2014)
Research Fellow @ (January 1996 - January 2003)
Analytical Associate and Contract Testing Liason @ (May 1987 - September 1991)
Mark Rose Education
The University of Kansas
Ph.D. (Pharmaceutical Chemistry)
1991-1996
Penn State University
BS (Chemistry)
1983-1987
North Hills High School
High School Diploma
1979-1983
Mark Rose Summary
Mark Rose, based in San Diego, CA, US, is currently a Vice President of DMPK and Nonclinical Safety at Spyre Therapeutics. Mark Rose brings experience from previous roles at DTx Pharma, Gossamer Bio, CHDI Management, Inc. and Amgen. Mark Rose holds a 1991 - 1996 Ph.D. in Pharmaceutical Chemistry @ The University of Kansas. Mark Rose has 1 emails on RocketReach.
Looking for a different Mark Rose?
Find contact details for 700 million professionals.